Therapeutic targeting of mammary cancer cell invasiveness: CEBP/β increases Junctional adhesion molecule A (JAM-A) expression via down regulation of its target gene, 28/October/2013, 8.24 am

Therapeutic targeting of mammary cancer cell motility and invasiveness: RREB1 [Ras responsive element (RRE) binding protein] increases Fascin expression via down regulation of its target gene, 28/November/2013, 8.21 am
November 28, 2013
Therapetic targeting of Glucose pathways: Anticancer drug Epirubicin inhibits Glucose phosphate isomerase expression via up regulation of its target gene, 29/October/2013, 6.26 am
November 29, 2013
Show all

Idea Proposed byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Therapeutic targeting of mammary cancer cell invasiveness: CEBP/β increases Junctional adhesion molecule A (JAM-A) expression via down regulation of its target gene, 28/October/2013, 8.24 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Comments are closed.